[Form 4] Centene Corporation Insider Trading Activity

Rhea-AI Filing Summary

Centene Corporation (CNC) – Form 4 insider activity

Director Christopher J. Coughlin reported one transaction dated 30 June 2025. He acquired 556 shares of Centene common stock at a stated price of $0, indicating the shares were received without cash consideration (e.g., settlement of equity awards as reflected by the filing). Following the transaction, Mr. Coughlin’s direct holdings increased to 11,435.926 shares. The filing also discloses indirect ownership of 30,054 shares held in a grantor-retained annuity trust (GRAT) for the benefit of Mr. Coughlin and his adult children, for which he is sole trustee.

Table II lists a previously granted option for 10,000 shares with a $80.57 exercise price, exercisable beginning 7 Feb 2025 and expiring 7 Feb 2032. No new derivative transaction was reported in this filing.

Key takeaways for investors

• The filing records a modest increase in insider ownership without any share sales.
• Cumulative direct and indirect equity exposure now totals ~41,490 shares, aligning director interests with shareholders.
• No material change to option positions; the 10,000-share option remains outstanding.

The transaction is routine in size relative to Centene’s market capitalization but may be interpreted as a marginally positive signal given the absence of dispositions.

Positive

• Director increased direct holdings by 556 shares, signalling continued insider alignment with shareholders.
• No insider sales disclosed, reducing concerns over potential negative sentiment.

Negative

• Transaction size is small relative to Centene’s share count and unlikely to influence market perception materially.

Insights

Financial Analyst

TL;DR: Small acquisition (556 shares) by CNC director raises direct stake to 11.4k; no sales reported—slightly positive but not financially material.

The Form 4 shows Mr. Coughlin augmenting his position at a recorded price of $0, typically reflecting RSU vesting. While the size—worth roughly US$45–50k at recent prices—is immaterial to Centene’s float, any director move that increases skin-in-the-game without concurrent sales is directionally constructive. Indirect exposure via a GRAT underscores longer-term estate planning rather than trading intent. The unchanged 10k option grant suggests no fresh option exercises or repricing events.

Overall impact on valuation, liquidity, or governance is minimal; however, continued accumulation by board members modestly reinforces alignment with shareholder interests.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TANJI KENNETH

(Last) (First) (Middle)

7700 FORSYTH BOULEVARD

(Street)

ST. LOUIS MO 63105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CENTENE CORP [ CNC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2025		A		463	A	$0	5,145(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ownership includes 3,579 shares of restricted stock units subject to vesting requirements.

Remarks:

	/s/ Christopher A. Koster (executed by attorney-in-fact)	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Centene (CNC) shares did Director Christopher J. Coughlin acquire?

He acquired 556 shares of common stock on 30 June 2025.

What is Christopher Coughlin’s total Centene share ownership after the transaction?

Direct ownership stands at 11,435.926 shares; he also controls 30,054 shares indirectly via a GRAT.

Did the insider sell any Centene shares in this Form 4?

No sales were reported; only an acquisition of 556 shares is disclosed.

Were any stock options exercised in this filing?

No option exercise occurred; the filing only lists an existing option for 10,000 shares exercisable from 7 Feb 2025 at $80.57.

Is the reported transaction material to Centene investors?

The acquisition is small relative to Centene’s market cap and is considered not materially impactful.